Clinical Trial Update: Modafinil for Atypical Depression [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating modafinil for atypical depression has completed Phase 2 and Phase 3; the update does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Depression

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Duke University | Conditions: Atypical Depression | Phase 2, Phase 3 | Status: COMPLETED